N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2)

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 28 USDMF, 9 CEP/COS, 9 JDMF, 7 EU WC, 1 VMF, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers, 49 FDA Orange Book, 17 Europe, 67 Canada, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 12 DKSH, 1 Jai Radhe Sales, 2 Nippon Fine Chemical, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 18 Actylis, 1 Alcedo Pharmachem, 23 BASF, 2 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 4 Finar, 5 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 9 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Topical, 35 Solubilizers, 32 Parenteral, 31 Thickeners and Stabilizers, 23 Coating Systems & Additives, 19 Film Formers & Plasticizers, 19 Fillers, Diluents & Binders, 11 Surfactant & Foaming Agents, 11 Rheology Modifiers, 11 Controlled & Modified Release, 10 Taste Masking, 10 Emulsifying Agents, 10 Co-Processed Excipients, 8 Empty Capsules, 5 Direct Compression, 5 Chewable & Orodispersible Aids, 5 Lubricants & Glidants, 4 API Stability Enhancers, 4 Granulation, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

32 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 1 US Exclusivities

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Ondine Biomedical

Canada

ASC 2024

Not Confirmed

Find Clinical Drug Pipeline Developments & Deals for N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2)